MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 112 filers reported holding MEI PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $248,000 | -35.1% | 641,050 | +1.4% | 0.01% | -30.8% |
| Q2 2022 | $382,000 | +51.6% | 632,200 | +50.9% | 0.01% | +62.5% |
| Q1 2022 | $252,000 | -40.4% | 418,950 | +164.6% | 0.01% | -33.3% |
| Q4 2021 | $423,000 | +6.3% | 158,350 | +9.7% | 0.01% | 0.0% |
| Q3 2021 | $398,000 | +65.1% | 144,350 | +70.9% | 0.01% | +71.4% |
| Q2 2021 | $241,000 | -11.7% | 84,450 | +6.3% | 0.01% | -22.2% |
| Q1 2021 | $273,000 | +30.0% | 79,450 | 0.0% | 0.01% | +28.6% |
| Q4 2020 | $210,000 | +0.5% | 79,450 | +18.7% | 0.01% | -12.5% |
| Q3 2020 | $209,000 | – | 66,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |